• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改造CRISPR/Cas9系统以靶向线粒体基因组。

Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome.

作者信息

Hussain Syed-Rehan A, Yalvac Mehmet E, Khoo Benedict, Eckardt Sigrid, McLaughlin K John

机构信息

Center for Molecular and Human Genetics, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.

Center for Clinical and Translational Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.

出版信息

Front Genet. 2021 Apr 6;12:627050. doi: 10.3389/fgene.2021.627050. eCollection 2021.

DOI:10.3389/fgene.2021.627050
PMID:33889176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8055930/
Abstract

Gene editing of the mitochondrial genome using the CRISPR-Cas9 system is highly challenging mainly due to sub-efficient delivery of guide RNA and Cas9 enzyme complexes into the mitochondria. In this study, we were able to perform gene editing in the mitochondrial DNA by appending an NADH-ubiquinone oxidoreductase chain 4 (ND4) targeting guide RNA to an RNA transport-derived stem loop element (RP-loop) and expressing the Cas9 enzyme with a preceding mitochondrial localization sequence. We observe mitochondrial colocalization of RP-loop gRNA and a marked reduction of ND4 expression in the cells carrying a 11205G variant in their ND4 sequence coincidently decreasing the mtDNA levels. This proof-of-concept study suggests that a stem-loop element added sgRNA can be transported to the mitochondria and functionally interact with Cas9 to mediate sequence-specific mtDNA cleavage. Using this novel approach to target the mtDNA, our results provide further evidence that CRISPR-Cas9-mediated gene editing might potentially be used to treat mitochondrial-related diseases.

摘要

使用CRISPR-Cas9系统对线粒体基因组进行基因编辑极具挑战性,主要原因是向导RNA和Cas9酶复合物向线粒体的递送效率低下。在本研究中,我们通过将靶向烟酰胺腺嘌呤二核苷酸-泛醌氧化还原酶链4(ND4)的向导RNA附加到RNA转运衍生的茎环元件(RP环)上,并表达带有先前线粒体定位序列的Cas9酶,从而能够在线粒体DNA中进行基因编辑。我们观察到RP环向导RNA在线粒体中的共定位,并且在其ND4序列中携带11205G变体的细胞中,ND4表达显著降低,同时线粒体DNA水平也随之下降。这项概念验证研究表明,添加了茎环元件的单向导RNA可以转运到线粒体中,并与Cas9发生功能相互作用,从而介导序列特异性线粒体DNA切割。利用这种针对线粒体DNA的新方法,我们的结果进一步证明,CRISPR-Cas9介导的基因编辑可能有潜力用于治疗线粒体相关疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/3e8ba788bd23/fgene-12-627050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/dfb9911e80fd/fgene-12-627050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/edebdaa377e2/fgene-12-627050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/b8e782949c00/fgene-12-627050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/3e8ba788bd23/fgene-12-627050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/dfb9911e80fd/fgene-12-627050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/edebdaa377e2/fgene-12-627050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/b8e782949c00/fgene-12-627050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67d4/8055930/3e8ba788bd23/fgene-12-627050-g004.jpg

相似文献

1
Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome.改造CRISPR/Cas9系统以靶向线粒体基因组。
Front Genet. 2021 Apr 6;12:627050. doi: 10.3389/fgene.2021.627050. eCollection 2021.
2
Efficient Mitochondrial Genome Editing by CRISPR/Cas9.利用CRISPR/Cas9进行高效的线粒体基因组编辑
Biomed Res Int. 2015;2015:305716. doi: 10.1155/2015/305716. Epub 2015 Sep 10.
3
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
4
Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing.CRISPR-Cas9介导的线粒体基因组编辑的直接证据。
Innovation (Camb). 2022 Sep 27;3(6):100329. doi: 10.1016/j.xinn.2022.100329. eCollection 2022 Nov 8.
5
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.支架介导的非病毒递送平台用于基于 CRISPR/Cas9 的基因组编辑。
Acta Biomater. 2019 May;90:60-70. doi: 10.1016/j.actbio.2019.04.020. Epub 2019 Apr 9.
6
Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.两种不同的 CRISPR-Cas9 介导的基因编辑方法在新型隐球菌及相关种属中的应用。
mSphere. 2018 Jun 13;3(3). doi: 10.1128/mSphereDirect.00208-18. Print 2018 Jun 27.
7
Cas9/gRNA-mediated genome editing of yeast mitochondria and chloroplasts.Cas9/gRNA介导的酵母线粒体和叶绿体基因组编辑。
PeerJ. 2020 Jan 6;8:e8362. doi: 10.7717/peerj.8362. eCollection 2020.
8
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.利什曼原虫中CRISPR-Cas9介导的基因组编辑
mBio. 2015 Jul 21;6(4):e00861. doi: 10.1128/mBio.00861-15.
9
Dramatic Improvement of CRISPR/Cas9 Editing in by Increased Single Guide RNA Expression.通过增加单向导RNA表达显著改善CRISPR/Cas9编辑
mSphere. 2017 Apr 19;2(2). doi: 10.1128/mSphere.00385-16. eCollection 2017 Mar-Apr.
10
Development of a CRISPR/Cas9 System for Methylococcus capsulatus Gene Editing.开发用于甲基球菌基因编辑的 CRISPR/Cas9 系统。
Appl Environ Microbiol. 2019 May 16;85(11). doi: 10.1128/AEM.00340-19. Print 2019 Jun 1.

引用本文的文献

1
Lipid nanoparticle delivery of the CRISPR/Cas9 system directly into the mitochondria of cells carrying m.7778G>T mutation in MtDNA (mt-Atp8).将CRISPR/Cas9系统通过脂质纳米颗粒直接递送至线粒体DNA(mt-Atp8)携带m.7778G>T突变的细胞线粒体中。
Sci Rep. 2025 Jun 19;15(1):18717. doi: 10.1038/s41598-025-03671-8.
2
Pioneering Advances and Innovative Applications of Mesoporous Carriers for Mitochondria-Targeted Therapeutics.介孔载体用于线粒体靶向治疗的开创性进展与创新应用
Br J Biomed Sci. 2024 Nov 18;81:13707. doi: 10.3389/bjbs.2024.13707. eCollection 2024.
3
Emerging Multi-omic Approaches to the Molecular Diagnosis of Mitochondrial Disease and Available Strategies for Treatment and Prevention.

本文引用的文献

1
Use of Customizable Nucleases for Gene Editing and Other Novel Applications.定制核酸内切酶在基因编辑及其他新应用中的使用。
Genes (Basel). 2020 Aug 22;11(9):976. doi: 10.3390/genes11090976.
2
A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.一种细菌胞嘧啶脱氨酶毒素可实现无 CRISPR 的线粒体碱基编辑。
Nature. 2020 Jul;583(7817):631-637. doi: 10.1038/s41586-020-2477-4. Epub 2020 Jul 8.
3
Can Mitochondrial DNA be CRISPRized: Pro and Contra.线粒体 DNA 能否被 CRISPR 化:赞成与反对。
线粒体疾病分子诊断的新兴多组学方法及可用的治疗与预防策略
Curr Genomics. 2024;25(5):358-379. doi: 10.2174/0113892029308327240612110334. Epub 2024 Jun 14.
4
Streamlined process for effective and strand-selective mitochondrial base editing using mitoBEs.使用线粒体碱基编辑器(mitoBEs)进行有效且链特异性线粒体碱基编辑的简化流程。
Biophys Rep. 2024 Aug 31;10(4):191-200. doi: 10.52601/bpr.2024.240010.
5
Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy.线粒体基因组编辑:探索动脉粥样硬化相关突变m.15059G>A与线粒体自噬缺陷之间的潜在关系
J Lipid Atheroscler. 2024 May;13(2):166-183. doi: 10.12997/jla.2024.13.2.166. Epub 2024 Apr 18.
6
Tools for editing the mammalian mitochondrial genome.用于编辑哺乳动物线粒体基因组的工具。
Hum Mol Genet. 2024 May 22;33(R1):R92-R99. doi: 10.1093/hmg/ddae037.
7
CRISPR Advancements for Human Health.CRISPR 技术在人类健康领域的应用进展。
Mo Med. 2024 Mar-Apr;121(2):170-176.
8
CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering.CRISPR/Cas9 介导的碱基编辑器及其在线粒体基因组工程中的应用前景。
Gene Ther. 2024 May;31(5-6):209-223. doi: 10.1038/s41434-023-00434-w. Epub 2024 Jan 4.
9
The applications of CRISPR/Cas-mediated microRNA and lncRNA editing in plant biology: shaping the future of plant non-coding RNA research.CRISPR/Cas 介导的 microRNA 和 lncRNA 编辑在植物生物学中的应用:塑造植物非编码 RNA 研究的未来。
Planta. 2023 Dec 28;259(2):32. doi: 10.1007/s00425-023-04303-z.
10
Leber hereditary optic neuropathy gene therapy.Leber 遗传性视神经病变基因治疗。
Curr Opin Ophthalmol. 2024 May 1;35(3):244-251. doi: 10.1097/ICU.0000000000001028. Epub 2023 Dec 20.
IUBMB Life. 2018 Dec;70(12):1233-1239. doi: 10.1002/iub.1919. Epub 2018 Sep 5.
4
Emerging therapies for mitochondrial diseases.线粒体疾病的新兴疗法。
Essays Biochem. 2018 Jul 20;62(3):467-481. doi: 10.1042/EBC20170114.
5
Anti-replicative recombinant 5S rRNA molecules can modulate the mtDNA heteroplasmy in a glucose-dependent manner.抗复制重组 5S rRNA 分子可以以葡萄糖依赖的方式调节 mtDNA 异质性。
PLoS One. 2018 Jun 18;13(6):e0199258. doi: 10.1371/journal.pone.0199258. eCollection 2018.
6
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.线粒体 DNA 异质性水平和拷贝数表明 m.3243A>G 线粒体疾病的疾病负担。
EMBO Mol Med. 2018 Jun;10(6). doi: 10.15252/emmm.201708262.
7
Linear mitochondrial DNA is rapidly degraded by components of the replication machinery.线性线粒体 DNA 会被复制机制的组件迅速降解。
Nat Commun. 2018 Apr 30;9(1):1727. doi: 10.1038/s41467-018-04131-w.
8
Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized.线粒体基因组工程:这场革命或许不会被 CRISPR 化。
Trends Genet. 2018 Feb;34(2):101-110. doi: 10.1016/j.tig.2017.11.001. Epub 2017 Nov 24.
9
Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase).通过多核苷酸磷酸化酶(PNPase)探索线粒体微小RNA的导入途径。
J Mol Cell Cardiol. 2017 Sep;110:15-25. doi: 10.1016/j.yjmcc.2017.06.012. Epub 2017 Jul 11.
10
Novel biallelic mutations in the PNPT1 gene encoding a mitochondrial-RNA-import protein PNPase cause delayed myelination.编码线粒体 RNA 导入蛋白 PNPase 的 PNPT1 基因中的新型双等位基因突变导致髓鞘形成延迟。
Clin Genet. 2018 Feb;93(2):242-247. doi: 10.1111/cge.13068. Epub 2017 Oct 4.